Summary of Purpose
In acute stroke patients about 20 % have known diabetes. There is a doubled risk of recurrent stroke in diabetic patients. It has been shown that antiplatelet drugs are not as effective in diabetic patients as in non-diabetic patients. In acute stroke patients around 80 % have impaired glucose tolerance, which will improve after one month till about 60 %. This study includes acute patients with minor stroke or...Read More →
The following dates are available for this trial. Trial information last updated on 22 August 2012.
|1 May 2010||18 Jul 2012||1 Jun 2013||1 Jun 2018||1 Aug 2012||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Observation: Cohort
- Perspective: Prospective
- Sampling: Probability Sample
- Ann Charlotte Laska, M.D.,Ph.D.